| abstract |
Oxazaquinazoline-7(8H)-ketone compound having selective inhibitory effect on KRAS gene mutation and pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof (represented by formula I or formula II, details (see definitions for each group of the formula herein), as well as pharmaceutical compositions containing the compounds, and their use in the manufacture of therapeutic agents for cancer. |